5,7-Dihydroxytryptamine injections into the prefrontal cortex and nucleus accumbens differently affect prepulse inhibition and baseline startle magnitude in rats

Behavioural Brain Research

Volumn 202, Issue 1, 2009, Pages 58-63

  Mohr, Daniela ^a   von Ameln Mayerhofer, Andreas ^a   Fendt, Markus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Animal model of schizophrenia; Depletion; Dopamine; Lesion; Sensorimotor gating; Serotonin

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; DOPAMINE; NEUROTRANSMITTER; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; EX VIVO STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; STARTLE REFLEX;

5,7-DIHYDROXYTRYPTAMINE; ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; CATHETERIZATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION; DOPAMINE; HYDROXYINDOLEACETIC ACID; MALE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; STARTLE REACTION;

EID: 67349136835     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.03.014     Document Type: Article

References (50)

1. Adamec R.E., Head D., Blundell J., Burton P., and Berton O. Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience. Physiol Behav 88 (2006) 12-29
2. Bakshi V.P., and Geyer M.A. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18 (1998) 8394-8401
3. Bakshi V.P., Swerdlow N.R., and Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271 (1994) 787-794
4. Bast T., Pezze M.A., and Feldon J. Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition. Behav Pharmacol 13 (2002) 669-673
5. Baylen C.A., and Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101 (2006) 933-947
6. Braff D.L., and Geyer M.A. Acute and chronic LSD effects on rat startle: data supporting an LSD-rat model of schizophrenia. Biol Psychiatry 15 (1980) 909-916
7. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156 (2001) 234-258
8. Braff D.L., Grillon C., and Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49 (1992) 206-215
9. Bubser M., and Koch M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology 113 (1994) 487-492
10. Duncan E.J., Szilagyi S., Efferen T.R., Schwartz M.P., Parwani A., Chakravorty S., et al. Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 53 (2003) 184S
11. Fendt M. Enhancement of prepulse inhibition after blockade of GABA activity within the superior colliculus. Brain Res 833 (1999) 81-85
12. Fletcher P.J., Selhi Z.F., Azampanah A., and Sills T.L. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex: effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Neuropsychopharmacology 24 (2001) 399-409
13. 2O)-O-15]-PET in healthy humans. Neuropsychopharmacology 23 (2000) 388-395
14. Geyer M.A. Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 31 (1998) 73-79
15. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156 (2001) 117-154
16. Geyer M.A., and Vollenweider F.X. Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 29 (2008) 445-453
17. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology (Berl) 163 (2002) 467-476
18. Grillon C., Pellowski M., Merikangas K.R., and Davis M. Darkness facilitates the acoustic startle reflex in humans. Biol Psychiatry 42 (1997) 453-460
19. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13 (1980) 453-456
20. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 30 (2006) 203-214
21. Hoffman H.S., and Searle J.L. Acoustic variables in the modification of startle reaction in the rat. J Comp Physiol Psychol 60 (1965) 53-58
22. Kehne J.H., Padich R.A., McCloskey T.C., Taylor V.L., and Schmidt C.J. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. Psychopharmacology 124 (1996) 95-106
23. Koch M. The neurobiology of startle. Prog Neurobiol 59 (1999) 107-128
24. Koch M., and Bubser M. Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur J Neurosci 6 (1994) 1837-1845
25. Kusljic S., Copolov D.L., and van den Buuse M. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. Neuropsychopharmacology 28 (2003) 2138-2147
26. Kusljic S., and van den Buuse M. Serotonin depletion in dorsal hippocampus in rats causes enhanced phencyclidine-induced locomotor hyperactivity and disruption of prepulse inhibition. Int J Neuropsychopharmacol 7 (2004) S294
27. Kusljic S., and van den Buuse M. Differential involvement of 5-HT projections within the amygdala in prepulse inhibition but not in psychotomimetic drug-induced hyperlocomotion. Behav Brain Res 168 (2006) 74-82
28. Lacroix L., Broersen L.M., Weiner I., and Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 82 (1998) 431-442
29. Lehner M., Taracha E., Turzynska D., Sobolewska A., Hamed A., Kolomanska P., et al. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies. Behav Brain Res 192 (2008) 203-215
30. Ludwig V., and Schwarting R.K.W. Neurochemical and behavioral consequences of striatal injection of 5,7-dihydroxytryptamine. J Neurosci Meth 162 (2007) 108-118
31. Mansbach R.S., Braff D.L., and Geyer M.A. Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. Eur J Pharmacol 167 (1989) 49-55
32. Mansbach R.S., Geyer M.A., and Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94 (1988) 507-514
33. Martinez D.L., and Geyer M.A. Characterization of the disruptions of prepulse inhibition and habituation of startle induced by α-ethyltryptamine. Neuropsychopharmacology 16 (1997) 246-255
34. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
35. Mohr D., Lettfuss N., Fisch N., Mayerhofer A., and Fendt M. Acute and long-term effect of MDMA on startle reflex and prepulse inhibition in rats. Behav Pharmacol 18 (2007) S14
36. Ogren S.O., Johansson C., and Magnusson O. Forebrain serotonergic involvement in avoidance learning. Neurosci Lett 58 (1985) 305-309
37. Oranje B., van Oel C.J., Gispen-De Wied M.N., and Kahns R.S. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol 22 (2002) 359-365
38. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology 124 (1996) 107-116
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
40. Plappert C.F., Pilz P.K.D., and Schnitzler H.-U. Acoustic startle response and habituation in freezing and nonfreezing rats. Behav Neurosci 107 (1993) 981-987
41. Prinssen E.P., Assié M.B., Koek W., and Kleven M.S. Depletion of 5-HT disrupts prepulse inhibition in rats: dependence on the magnitude of depletion, and reversal by a 5-HT precursor. Neuropsychopharmacology 26 (2002) 340-347
42. Sawynok J., and Reid A. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats. J Pharmacol Exp Ther 277 (1996) 646-653
43. Sipes T.A., and Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33 (1994) 441-448
44. Smith J.E., Shultz K., Co C., Goeders N.E., and Dworkin S.I. Effects of 5,7-dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine self-administration. Pharmacol Biochem Behav 26 (1987) 607-612
45. Swerdlow N.R., Braff D.L., Taaid N., and Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51 (1994) 139-154
46. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156 (2001) 194-215
47. Swerdlow N.R., Shoemaker J.M., Kuczenski R., Bongiovanni M.J., Neary A.C., Tochen L.S., et al. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Neurosci Lett 402 (2006) 40-45
48. van den Buuse M., and Eikelis N. Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425 (2001) 33-41
49. van den Buuse M., Garner B., and Koch M. Neurodevelopmental animal models of schizophrenia: effects on prepulse inhibition. Curr Mol Med 3 (2003) 459-471
50. Walker D.L., and Davis M. Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology 159 (2002) 304-310